Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients

Robert A. Fowler; Nicole Mittmann; William Geerts; Diane Heels-Ansdell; Michael K. Gould; Gordon Guyatt; Murray Krahn; Simon Finfer; Ruxandra Pinto; Brian Chan; Orges Ormanidhi; Yaseen Arabi; Ismael Qushmaq; Marcelo G. Rocha; Peter Dodek; Lauralyn McIntyre; Richard Hall; Niall D. Ferguson; Sangeeta Mehta; John C. Marshall; Christopher James Doig; John Muscedere; Michael J. Jacka; James R. Klinger; Nicholas Vlahakis; Neil Orford; Ian Seppelt; Yoanna K. Skrobik; Sachin Sud; John F. Cade; Jamie Cooper; Deborah Cook

doi:10.1001/jama.2014.15101

Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients

Robert A. Fowler, Nicole Mittmann, William Geerts, Diane Heels-Ansdell, Michael K. Gould, Gordon Guyatt, Murray Krahn, Simon Finfer, Ruxandra Pinto, Brian Chan, Orges Ormanidhi, Yaseen Arabi, Ismael Qushmaq, Marcelo G. Rocha, Peter Dodek, Lauralyn McIntyre, Richard Hall, Niall D. Ferguson, Sangeeta Mehta, John C. MarshallChristopher James Doig, John Muscedere, Michael J. Jacka, James R. Klinger, Nicholas Vlahakis, Neil Orford, Ian Seppelt, Yoanna K. Skrobik, Sachin Sud, John F. Cade, Jamie Cooper, Deborah Cook

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

Original language	English
Pages (from-to)	2135-2145
Number of pages	11
Journal	JAMA - Journal of the American Medical Association
Volume	312
Issue number	20
DOIs	https://doi.org/10.1001/jama.2014.15101
Publication status	Published - Nov 26 2014
Externally published	Yes

ASJC Scopus Subject Areas

General Medicine

Access to Document

10.1001/jama.2014.15101

Cite this

Fowler, R. A., Mittmann, N., Geerts, W., Heels-Ansdell, D., Gould, M. K., Guyatt, G., Krahn, M., Finfer, S., Pinto, R., Chan, B., Ormanidhi, O., Arabi, Y., Qushmaq, I., Rocha, M. G., Dodek, P., McIntyre, L., Hall, R., Ferguson, N. D., Mehta, S., ... Cook, D. (2014). Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients. JAMA - Journal of the American Medical Association, 312(20), 2135-2145. https://doi.org/10.1001/jama.2014.15101

Fowler, RA, Mittmann, N, Geerts, W, Heels-Ansdell, D, Gould, MK, Guyatt, G, Krahn, M, Finfer, S, Pinto, R, Chan, B, Ormanidhi, O, Arabi, Y, Qushmaq, I, Rocha, MG, Dodek, P, McIntyre, L, Hall, R, Ferguson, ND, Mehta, S, Marshall, JC, James Doig, C, Muscedere, J, Jacka, MJ, Klinger, JR, Vlahakis, N, Orford, N, Seppelt, I, Skrobik, YK, Sud, S, Cade, JF, Cooper, J & Cook, D 2014, 'Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients', JAMA - Journal of the American Medical Association, vol. 312, no. 20, pp. 2135-2145. https://doi.org/10.1001/jama.2014.15101

@article{00c59a166513452e868ebe08eab67c1e,

title = "Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients",

author = "Fowler, {Robert A.} and Nicole Mittmann and William Geerts and Diane Heels-Ansdell and Gould, {Michael K.} and Gordon Guyatt and Murray Krahn and Simon Finfer and Ruxandra Pinto and Brian Chan and Orges Ormanidhi and Yaseen Arabi and Ismael Qushmaq and Rocha, {Marcelo G.} and Peter Dodek and Lauralyn McIntyre and Richard Hall and Ferguson, {Niall D.} and Sangeeta Mehta and Marshall, {John C.} and {James Doig}, Christopher and John Muscedere and Jacka, {Michael J.} and Klinger, {James R.} and Nicholas Vlahakis and Neil Orford and Ian Seppelt and Skrobik, {Yoanna K.} and Sachin Sud and Cade, {John F.} and Jamie Cooper and Deborah Cook",

year = "2014",

month = nov,

day = "26",

doi = "10.1001/jama.2014.15101",

language = "English",

volume = "312",

pages = "2135--2145",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "20",

}

TY - JOUR

T1 - Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients

AU - Fowler, Robert A.

AU - Mittmann, Nicole

AU - Geerts, William

AU - Heels-Ansdell, Diane

AU - Gould, Michael K.

AU - Guyatt, Gordon

AU - Krahn, Murray

AU - Finfer, Simon

AU - Pinto, Ruxandra

AU - Chan, Brian

AU - Ormanidhi, Orges

AU - Arabi, Yaseen

AU - Qushmaq, Ismael

AU - Rocha, Marcelo G.

AU - Dodek, Peter

AU - McIntyre, Lauralyn

AU - Hall, Richard

AU - Ferguson, Niall D.

AU - Mehta, Sangeeta

AU - Marshall, John C.

AU - James Doig, Christopher

AU - Muscedere, John

AU - Jacka, Michael J.

AU - Klinger, James R.

AU - Vlahakis, Nicholas

AU - Orford, Neil

AU - Seppelt, Ian

AU - Skrobik, Yoanna K.

AU - Sud, Sachin

AU - Cade, John F.

AU - Cooper, Jamie

AU - Cook, Deborah

PY - 2014/11/26

Y1 - 2014/11/26

UR - http://www.scopus.com/inward/record.url?scp=84914171147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914171147&partnerID=8YFLogxK

U2 - 10.1001/jama.2014.15101

DO - 10.1001/jama.2014.15101

M3 - Article

C2 - 25362228

AN - SCOPUS:84914171147

SN - 0098-7484

VL - 312

SP - 2135

EP - 2145

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 20

ER -

Cost-effectiveness of Dalteparin vs Unfractionated heparin for the prevention of venous Thromboembolism in Critically Ill patients

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this